Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
Collaboration between TLI and AMDF underscores a shared commitment to making a meaningful difference in the lives of those affected by AMD. Together, TLI and AMDF are dedicated to advancing awareness, ...
The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...
Our eyesight is essential to getting around, but if you’re not careful it can be seriously challenged by age-related macular degeneration.
In response to the TGA's approval of a new drug to treat macular degeneration, UNSW researcher Dr Lisa Nivison-Smith provides context about the ...